Stephen Saad, Group Chief Executive, Aspen
The line between research based pharmaceutical companies and generic companies is today less and less relevant, as we have seen in the past few years generic companies climb up the…
Address: 65 Peter Place
Bryanston Extension 13
2021 Republic of South Africa
Tel: +27 11 840 2300
Web: http://www.alcon.com/en/alcon-locations/africa.aspx
Founded in 1945, Alcon traces its roots back to two pharmacists, Robert Alexander and William Conner, who opened a small pharmacy in Fort Worth, Texas, and combined the first syllables of their last names to create the name Alcon.
The strengths of Alcon, CIBA VISION and Novartis Ophthalmics unite into one eye care business with Alcon becoming the second largest division of Novartis. With these collective resources and scale, Alcon offers the widest spectrum of eye care products in Surgical, Pharmaceutical and Vision Care across 180 markets and runs operations in 75 countries.
Incorporated in 1977, Alcon South Africa employs nearly 90 people focused on serving the needs of health care professionals in the area.
Alcon develops, manufactures and markets surgical equipment and devices, pharmaceuticals and vision care products in more than 180 countries. At the heart of Alcon’s ability to deliver ‘best in class’ products year after year is our Research & Development organization. All of our many engineers, scientists and medical professionals are dedicated to meeting the world’s eye health needs. In 2010, we invested USD 747 million in the pursuit of new products to enhance, preserve and restore vision. Over the next five years, Alcon plans to invest approximately USD 4 billion to discover and develop new treatment solutions for vision conditions and eye diseases.
The line between research based pharmaceutical companies and generic companies is today less and less relevant, as we have seen in the past few years generic companies climb up the…
Mr. Godard, you previously worked in Europe for Baxter Edwards Life Sciences, what made you decide to move to South Africa in a smaller company? It is a purely romantic…
Your professional career went back and forth between creating your own business and running a smaller and very dynamic structure and managing over a thousand of employees for multinational organizations.…
You were recently appointed at the head of Eli Lilly South African operations. What is the specific mission you have been given? Eli Lilly South Africa is in an interesting…
Since we interviewed you in 2005, there have been many changes in the market, from consolidation, an increasing generic penetration, to new healthcare reforms… How have you integrated these changes…
An emerging country with a dynamic market, South Africa is widely seen as the gateway to Africa. From major multinational pharmaceutical corporations to burgeoning local generic companies, a wide…
We interviewed Graham Somerville in 2004, the year when IHD, formerly jointly owned by 11 major pharmaceutical companies, was acquired by UTi. We are interviewing you today at the head…
Dr Pillay, South Africa recently became a member of BRICS. With this distinction, we need to improve our healthcare outcomes relative to other BRICS countries. All countries have challenges with…
The South African affiliate was established in June 2003. Could you come back on the main milestones in the company’s development from 2003 onwards? Yamanouchi as an entity was an…
Since we that came to South Africa in 2005 and interviewed you, what have been the main changes both in the market place, and within Sanofi as an organization? The…
In 2005, when Focus Reports interviewed you, you were more towards the start up phase of Pharma Dynamics; and you have significantly grown in the market since then. What new…
Mr. Ehsan, you are the General Manager of IMS Africa since January 2010. What is the strategic importance of South Africa for IMS Global and for your personal country portfolio?…
See our Cookie Privacy Policy Here
